Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stek

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 16, 2010
Lopinavir tablet pharmacokinetics with an increased dose during pregnancyBrookie M Best, Alice M Stek, Mark Mirochnick, et al.
Journal of Clinical Pharmacology|October 26, 2018
Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and PostpartumAhizechukwu C Eke, Shelley A McCormack, Brookie M Best, et al.
The New England Journal of Medicine|June 14, 2002
Antiretroviral therapy during pregnancy and the risk of an adverse outcomeRuth E Tuomala, David E Shapiro, Lynne M Mofenson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2011
Atazanavir pharmacokinetics with and without tenofovir during pregnancyMark Mirochnick, Brookie M Best, Alice M Stek, et al.
AIDS (London, England)|September 22, 2006
Reduced lopinavir exposure during pregnancyAlice M Stek, Mark Mirochnick, Edmund Capparelli, et al.
HIV Medicine|December 2, 2011
Effect of pregnancy on emtricitabine pharmacokineticsA M Stek, B M Best, W Luo, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant womenEdward P Acosta, Arlene Bardeguez, Carmen D Zorrilla, et al.
HIV Medicine|September 18, 2008
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartumJ S Read, B M Best, A M Stek, et al.
Frontiers in Pharmacology|August 20, 2016
Etravirine Pharmacokinetics in HIV-Infected Pregnant WomenNikki Mulligan, Stein Schalkwijk, Brookie M Best, et al.
AIDS (London, England)|June 17, 1999
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in uteroO A Olivero, G M Shearer, C A Chougnet, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|July 16, 2010
Lopinavir tablet pharmacokinetics with an increased dose during pregnancyBrookie M Best, Alice M Stek, Mark Mirochnick, et al.
Journal of Clinical Pharmacology|October 26, 2018
Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and PostpartumAhizechukwu C Eke, Shelley A McCormack, Brookie M Best, et al.
The New England Journal of Medicine|June 14, 2002
Antiretroviral therapy during pregnancy and the risk of an adverse outcomeRuth E Tuomala, David E Shapiro, Lynne M Mofenson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2011
Atazanavir pharmacokinetics with and without tenofovir during pregnancyMark Mirochnick, Brookie M Best, Alice M Stek, et al.
AIDS (London, England)|September 22, 2006
Reduced lopinavir exposure during pregnancyAlice M Stek, Mark Mirochnick, Edmund Capparelli, et al.
HIV Medicine|December 2, 2011
Effect of pregnancy on emtricitabine pharmacokineticsA M Stek, B M Best, W Luo, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant womenEdward P Acosta, Arlene Bardeguez, Carmen D Zorrilla, et al.
HIV Medicine|September 18, 2008
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartumJ S Read, B M Best, A M Stek, et al.
Frontiers in Pharmacology|August 20, 2016
Etravirine Pharmacokinetics in HIV-Infected Pregnant WomenNikki Mulligan, Stein Schalkwijk, Brookie M Best, et al.
AIDS (London, England)|June 17, 1999
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in uteroO A Olivero, G M Shearer, C A Chougnet, et al.
Pageof 5